The molecular basis of JAK/STAT inhibition by SOCS1

Nicholas P. D. Liau(Denali Therapeutics (United States)), Jeffrey J. Babon(The University of Melbourne)
Nature Communications
April 13, 2018
Cited by 453


Related Papers